- Home
- YMAB vs LZM Comparison
YMAB vs LZM Comparison
Compare YMAB & LZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- LZM
- Stock Information
- Founded
- YMAB 2015
- LZM 2021
- Country
- YMAB United States
- LZM Isle of Man
- Employees
- YMAB N/A
- LZM N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- LZM Metal Mining
- Sector
- YMAB Health Care
- LZM Basic Materials
- Exchange
- YMAB Nasdaq
- LZM Nasdaq
- Market Cap
- YMAB 482.4M
- LZM 528.1M
- IPO Year
- YMAB 2018
- LZM N/A
- Fundamental
- Price
- YMAB $6.19
- LZM $6.57
- Analyst Decision
- YMAB Strong Buy
- LZM Strong Buy
- Analyst Count
- YMAB 10
- LZM 2
- Target Price
- YMAB $21.10
- LZM $12.50
- AVG Volume (30 Days)
- YMAB 417.3K
- LZM 110.7K
- Earning Date
- YMAB 02-27-2025
- LZM 01-28-2025
- Dividend Yield
- YMAB N/A
- LZM N/A
- EPS Growth
- YMAB N/A
- LZM N/A
- EPS
- YMAB N/A
- LZM N/A
- Revenue
- YMAB $84,553,000.00
- LZM $1,020,728.00
- Revenue This Year
- YMAB $6.09
- LZM N/A
- Revenue Next Year
- YMAB $19.62
- LZM $890.00
- P/E Ratio
- YMAB N/A
- LZM N/A
- Revenue Growth
- YMAB N/A
- LZM N/A
- 52 Week Low
- YMAB $6.01
- LZM $4.52
- 52 Week High
- YMAB $20.90
- LZM $9.51
- Technical
- Relative Strength Index (RSI)
- YMAB 19.68
- LZM 42.82
- Support Level
- YMAB $6.05
- LZM $6.38
- Resistance Level
- YMAB $6.81
- LZM $6.90
- Average True Range (ATR)
- YMAB 0.49
- LZM 0.25
- MACD
- YMAB -0.02
- LZM -0.04
- Stochastic Oscillator
- YMAB 6.90
- LZM 22.29
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About LZM Lifezone Metals Limited
Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises two segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary.